The Upside – EDBI E-Newsletter 2022 Q4
Reflecting on the year and new developments in Q4
- 10 01 2023
- |
Category: E-Newsletters
EDBI Newsletter 2021 Q4
Groundbreaking initiatives and portfolio companies’ achievements in 2021
- 05 01 2022
- |
EDBI Newsletter 2021 Q3
EDBI announces new pathbreaking initiatives and celebrates our portfolio companies’ public listings and world-leading achievements
- 01 10 2021
- |
EDBI Newsletter 2021 Q2
EDBI portfolio companies Sprinklr and WalkMe debuted on the NYSE and NASDAQ
respectively in June, bringing the number of IPOs from our portfolio this year
- 30 06 2021
- |
EDBI Newsletter 2021 Q1
SPAC wave arrives in Southeast Asia. The ongoing surge of SPAC-related activities
in the US arrived on the shores of Southeast Asia in recent months,
- 31 03 2021
- |
EDBI Newsletter 2020 Q4
As 2020 comes to a close, team EDBI took the opportunity to reflect on the market activity and
outlook for 2021.
- 31 12 2020
- |
Enhancing the development of the ASEAN markets and accelerating global market expansion for Chinese biopharma companies
Take a deep dive into the ASEAN biopharmaceutical landscape
- 20 12 2020
- |
EDBI Newsletter 2020 Q3
The pandemic has compelled companies to excel by building capabilities in innovation
and digitalization with support from investors and government, and in turn create
good jobs
- 30 09 2020
- |
EDBI Newsletter 2020 Q2
During the last quarter, the COVID-19 pandemic further transformed our investment landscape,
bringing consumers and companies to a standstill in more ways than one. Singapore’s
- 30 06 2020
- |
EDBI 2020 Q1 – Q1 2020
We trust you are staying safe and healthy during this difficult global pandemic.
- 31 03 2020
- |
